In the last several years, global market of Ibuprofen developed unstably, with an average growth rate of 0.44%. In 2016, global revenue of Ibuprofen was nearly 260 million USD; the actual production was about 25500 MT.
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
The classification of Ibuprofen includes USP and EP; and the sales proportion of USP Ibuprofen in 2016 was about 65.7%.
Ibuprofen is applied in Tablet, Capsule, Suspension and Other. The most proportion of Ibuprofen was used in Tablet, and the market share in 2016 was about 46%.
China was the largest supplier of Ibuprofen, with a production market share nearly 48% in 2016. India was the second largest supplier of Ibuprofen, enjoying production market share nearly 30.7% in 2016.
North America was the largest sales place, with a sales market share nearly 29.7% in 2016. Following North America, Europe was the second largest sales place with the sales market share of 26.2%.
Market competition is intense. Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry.
NYVNFanpage ytb！
